Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
Clinical trial NCT02161770 · COMPLETED
Trial details
- NCT number
- NCT02161770
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-22
- Primary completion
- 2017-05-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.